510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2336-2017Class II

Arrow Multi-Lumen CVC Kit The Arrow Two-Lumen Central Venous Access device permits venous access and catheter...

Arrow International LLC (subsidiary of Teleflex Incorporated) / initiated 2017-05-09 / Terminated / root cause: packaging

Arrow International Inc began a recall of Arrow Multi-Lumen CVC Kit The Arrow Two-Lumen Central Venous Access device permits venous access and catheter introduction to the central circulation on . FDA classified it as Class II and gives the reason as "The Arrow CVC is indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring central venous access including, but not limited to: -multiple infusions of fluids...". As of , the recall status on record is Terminated, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-2336-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Arrow International LLC (subsidiary of Teleflex Incorporated)
Product
Arrow Multi-Lumen CVC Kit The Arrow Two-Lumen Central Venous Access device permits venous access and catheter introduction to the central circulation.
Product code
DQY Catheter, Percutaneous
Reason for recall
The Arrow CVC is indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring central venous access including, but not limited to: -multiple infusions of fluids, medications, or chemotherapy -infusion of fluids that are hypertonic, hyperosmolar, or have divergent pH values -frequent blood sampling or blood/blood components infusions -infusion of incompatible medications -central venous pressure monitoring lack of usable peripheral IV sites -replacement of multiple peripheral sites for IV access
Root cause tag
packaging
FDA root cause
Packaging
Action
Arrow International sent an Urgent Medical Device Recall Notification Letter dated May 11, 2017, to affected customers. The firm's notification letter is requesting that customers immediately assess their current inventory and to discontinue and quarantine any product with the specific lot codes listed in the letter. In addition, customers were asked to complete the Recall Acknowledgement form and fax or email it back to Customer Service so they can receive a Returns Good Authorization Number for the product's return. Customers with questions were instructed to contact their local sales representative or Customer Service at 1-866-246-6990.
Quantity in commerce
27,485 units distributed in U.S., 4,371 units distributed internationally
Distribution
Worldwide Distribution - US (nationwide) and Canada
Product codes and lots
Material number: CDC-12703-1A, CDC-12802-1A, CDC-15703-1A, CDC-15703-B1A, CDC-15802-1A,  Device Listing E426708

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2336-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2327-2017Class IITerminatedVoluntary: Firm initiated
Z-2328-2017Class IITerminatedVoluntary: Firm initiated
Z-2329-2017Class IITerminatedVoluntary: Firm initiated
Z-2330-2017Class IITerminatedVoluntary: Firm initiated
Z-2331-2017Class IITerminatedVoluntary: Firm initiated
Z-2332-2017Class IITerminatedVoluntary: Firm initiated
Z-2333-2017Class IITerminatedVoluntary: Firm initiated
Z-2334-2017Class IITerminatedVoluntary: Firm initiated
Z-2335-2017Class IITerminatedVoluntary: Firm initiated
Z-2336-2017Class IITerminatedVoluntary: Firm initiated
Z-2337-2017Class IITerminatedVoluntary: Firm initiated
Z-2338-2017Class IITerminatedVoluntary: Firm initiated